Anti-cytokine and anti-endotoxin therapies for meningococcal disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 4, 2015, Pages

  Li, Yuning ^a   Zhou, Li ^b   Qiu, Jie ^b   Liu, Donghai ^b   Shi, Yongsheng ^b  

^a LANZHOU UNIVERSITY   (China)

^b Maternal and Children Hospital of Gansu Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85041827000     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004420.pub4     Document Type: Article

References (23)

1. Fergusion LE, Hormann MD. Neisseria Meningitidis: presentation, treatment and prevention. Journal of Pediatric Health Care 2002;16:119-24.
2. Flexner S. The results of the serum treatment in thirteen hundred cases of epidemic meningitis. Journal of Experimental Medicine 1913;17:553-76.
3. Girgis N, Sultan Y, Frenck RWJr, El-Gendy A, Farid Z, Mateczun A. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatric Infectious Disease Journal 1998;17:816-19.
4. Giroir BP, Quint PA, Barton P, Kirsch EA, Kitchen L, Goldstein B, et al. amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997;350:1439-43.
5. Gold R, Lepow ML, Goldschneider I, Draper TF, Gotshlich EC. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. Journal of Infectious Diseases 1979;140(5):690-7.
6. Hackett SJ, Thomson APJ, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. Journal of Medical Microbiology 2001;50(10):847-59.
7. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clinical Microbiology Reviews 2006;19:142-64.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2000]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2009.
10. Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatic Infectious Disease Journal 1996;15:967-78.
11. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook.org.
12. Marzouk O, Thomson AP, Sills JA, Hart CA, Harris F. Features and outcome in meningococcal disease presenting with maculopapular rash. Archives of Disease in Children 1991;66:485-7.
13. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM. Continuous plasma filtration in sepsis syndrome. Plasma filtration in Sepsis Study Group. Critical Care Medicine 1999;27:2096-104.
14. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
15. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcal, and Neisseria meningitides. Lancet 2007;369(9580):2196-210.
16. Thomson AP, Sills JA, Thomson APJ, Sills JA, Hart CA. Validation of the Glasgow Meningococcal Septicaemia Prognostic Score: a 10-year retrospective survey. Critical Care Medicine 1991;19:26-30.
17. Thorburn K, Baines P, Thomson APJ, Hart CA. Mortality in severe meningococcal disease. Archives of Disease in Children 2001;85:382-5.
18. Tikhomirov E, Santamaria M, Esteves K. Meningococcal disease: public health burden and control. World Health Statistics Quarterly 1997;50(3-4):170-7.
19. van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW. Plasma and whole blood exchange in meningococcal sepsis. Clinical Infectious Diseases 1992;15:424-30.
20. World Health Organization. WHO meningococcal disease. http://www.who.int/csr/disease/meningococcal/en/index.html (accessed 28 June 2010).
21. World Health Organization. WHO meningococcal meningitis. http://www.who.int/mediacentre/factsheets/fs141/en/(accessed 28 June 2010).
22. Wilder-Smith A, Memish Z. Meningococcal disease and travel. International Journal of Antimicrobial Agents 2003;21(2):102-6.
23. Hackett S, Baines P, Thomson A. Anti-cytokine and anti-endotoxin therapies in meningococcal disease. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD004420.pub2]